ClinVar Miner

Submissions for variant NM_002485.5(NBN):c.1594_1595delinsCA (p.Val532Gln)

dbSNP: rs1586053803
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001012338 SCV001172772 uncertain significance Hereditary cancer-predisposing syndrome 2019-09-11 criteria provided, single submitter clinical testing The c.1594_1595delGTinsCA variant (also known as p.V532Q), located in coding exon 11 of the NBN gene, results from an in-frame deletion of GT and insertion of CA at nucleotide positions 1594 to 1595. This results in the substitution of the valine residue for a glutamine residue at codon 532, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.